Arch Point Investors Intercept Pharmaceuticals, Inc. Transaction History

Arch Point Investors

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 26, 2019	SELL	$77.77 - $120.68 $58,327 - $90,510	-750 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$91.83 - $120.68 $68,872 - $90,510	750 New	750 $84,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

Stay updated on Arch Point Investors with notifications on news.